We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EBIO: Epoch Pharmaceuticals

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: michael_f_murphy9/28/2003 2:27:27 AM
   of 33
Epoch Biosciences fails to win DOD contract
Friday September 26, 6:15 pm ET

LOS ANGELES, Sept 26 (Reuters) - Epoch Biosciences Inc. (NasdaqSC:EBIO - News), a provider of products that accelerate genomic analysis, on Friday said it did not win a U.S. Department of Defense contract for a biological agent identification system.
Epoch, based in Bothell, Washington, was a finalist in the competition for the program.

The company said it did not include revenue from the DOD project in its forecasts and its outlook for the fiscal year is unchanged.

Shares of Epoch fell 19 percent to close at $2.89 on Nasdaq
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext